Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for TLPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 26.81M
March 31, 2026 30.16M
December 31, 2025 29.72M
September 30, 2025 30.74M
June 30, 2025 16.52M
March 31, 2025 15.00M
December 31, 2024 18.24M
September 30, 2024 21.01M
June 30, 2024 24.86M
March 31, 2024 28.77M
December 31, 2023 20.40M
September 30, 2023 23.26M
June 30, 2023 17.72M
March 31, 2023 26.29M
December 31, 2022 47.49M
September 30, 2022 48.31M
June 30, 2022 56.13M
March 31, 2022 71.97M
December 31, 2021 77.89M
September 30, 2021 72.26M
June 30, 2021 79.59M
March 31, 2021 87.35M
December 31, 2020 66.30M
September 30, 2020 66.18M
June 30, 2020 67.40M
Date Value
March 31, 2020 77.34M
December 31, 2019 91.36M
September 30, 2019 104.98M
June 30, 2019 115.11M
March 31, 2019 113.44M
December 31, 2018 120.53M
September 30, 2018 77.74M
June 30, 2018 64.62M
March 31, 2018 65.81M
December 31, 2017 75.55M
September 30, 2017 82.74M
June 30, 2017 78.19M
March 31, 2017 88.44M
December 31, 2016 99.99M
September 30, 2016 106.00M
June 30, 2016 113.57M
March 31, 2016 121.22M
December 31, 2015 127.78M
September 30, 2015 131.56M
June 30, 2015 63.56M
March 31, 2015 75.59M
December 31, 2014 86.45M
September 30, 2014 96.44M
June 30, 2014 100.37M
March 31, 2014 100.42M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Omeros Corp. 286.83M
Hyperion DeFi, Inc. 113.14M
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M

Total Assets (Quarterly) Related Metrics